Point-of-Care Molecular Diagnostics Market to Reach US$ 7.96 Billion by 2034 at 11.17% CAGR
The Point-of-care (POC) molecular diagnostics bring high-sensitivity genetic and infectious disease testing directly to the patient—such as in emergency rooms, clinics, or low-resource settings. Healthcare organizations, diagnostic laboratories, and research…
